Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/29/2007CA2653062A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007CA2652751A1 Pharmaceutical compositions and methods of using same
11/29/2007CA2652707A1 C-phenyl glycitol compound
11/29/2007CA2651769A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/29/2007CA2651733A1 Guava leaf extract powder and method for production thereof
11/29/2007CA2651700A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/28/2007EP1860101A1 Tartrate sale of isofagomine and methods of use
11/28/2007EP1859808A1 Novel sugar uptake activator and method for screening the same
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
11/28/2007EP1858867A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof
11/28/2007EP1858545A2 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
11/28/2007EP1858541A2 Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
11/28/2007EP1858501A1 Nmda receptor antagonists in the medical intervention of metabolic disorders
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP1618212B1 Mutations in the human pcsk9 gene associated to hypercholesterolemia
11/28/2007EP1480691A4 Agglomerated particles for aerosol drug delivery
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1399430B1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1328245B1 Dental care compositions
11/28/2007EP1115863B1 Ucp4
11/28/2007EP1019077B1 Novel exendin agonist compounds
11/28/2007CN101080411A Thiazolopyridinone derivates as MCH receptor antagonists
11/28/2007CN101080401A Substituted biaryl analogues
11/28/2007CN101080398A Method for the production of oxazoles by condensing aromatic aldehydes with alpha-ketoximes to N-oxides and then reacting the same with activated acid derivatives
11/28/2007CN101080392A Piperazinyl pyridine derivatives as anti-obesity agents
11/28/2007CN101080385A Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy)phenoxy)ethyl)phenyl)propanoic acid
11/28/2007CN101080383A Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
11/28/2007CN101080233A Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN101077881A 1-O-beta-D-glucopyranosylgeraniol-10,5-olide and use thereof
11/28/2007CN101077415A Water-bome suction-type medicinal composition
11/28/2007CN101077374A Traditional Chinese medicine for preventing and treating metabolism syndrome
11/28/2007CN101077372A Chinese medicinal materials composition for preventing and treating iron-deficiency anemia and method of making the same
11/28/2007CN101077360A Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof
11/28/2007CN101077342A Method for formulating nutrition replenisher special-purpose used for children amblyopia
11/28/2007CN101077341A Application of aurantio-obtusifolin or its derivates in preparing hypolipidemic drug
11/28/2007CN101077337A Vitamin injection used for promoting female animal estrus and Increasing breeding and preparation method thereof
11/28/2007CN101077179A Golden mushroom intelligence developmental porridge
11/28/2007CN101077156A Kudzu root whole soybean powder and its preparation method
11/28/2007CN101077151A Bitter melon antihypelipidemic bean product and its manufacturing method
11/28/2007CN101077108A Health-care tea and its preparing process
11/28/2007CN101077104A Gynostemma pentaphyllum tea
11/28/2007CN101077098A Weight losing tea
11/28/2007CN100351263C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351250C Nobel compounds having selective inhibiting effect at GSK3
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351232C Anti-obesity agent
11/28/2007CN100351231C Lipid metabolism improving agent
11/28/2007CN100350968C Modification of feeding behavior
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/28/2007CN100350917C Food composition and method of using same
11/28/2007CN100350915C Medicine for treating metabolism syndrome
11/28/2007CN100350912C Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid
11/28/2007CN100350902C Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300754 Identifying sequence variation in lipid metabolic pathway for use in diagnosis, prevention and treatment of cardiovascular and lipid metabolism disorders
11/27/2007US7300675 Lipolysis stimulator
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2336412C Medicament for treatment of diabetes
11/27/2007CA2306883C Fast-dissolving pharmaceutical composition comprising as-3201
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007CA2285332C Nutritional supplement for facilitating skeletal muscle adaptation to strenuous exercise and counteracting defatigation in asthenic individuals
11/27/2007CA2267932C Compositions for postgastrectomic mineral supply
11/22/2007WO2007133778A2 Methods to restore glycemic control
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132906A1 Benzylamine derivatives as cetp inhibitors
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007132718A1 Solid preparation comprising adenosine 5'-triphosphate or physiologically acceptable salt thereof
11/22/2007WO2007132472A1 A crystalline form b4 of atorvastatin magnesium and a process thereof
11/22/2007WO2007131996A1 Meta-xylylenediamine vanadate salts
11/22/2007WO2007131930A1 Tablet formulation comprising repaglinide and metformin
11/22/2007WO2007131907A2 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
11/22/2007WO2007131778A2 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
11/22/2007WO2007131622A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007WO2007131621A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131620A1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131619A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007WO2007131517A1 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
11/22/2007WO2007100695A9 Metabolic regulators and uses thereof
11/22/2007WO2007099553A3 1,3-dioxane carboxylic acids
11/22/2007WO2007081091A8 Rhodandse derivarives, a process for the preparation thereof and pharmaceutical composition containing the same
11/22/2007WO2007065023A3 Processes for obtaining lignan extracts and compositions containing the lignan extracts
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 1298